Q4 2023 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2024-02-13 · accession 0001999371-24-002152
$547.5M
Reported value
82
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $41.6M | 7.61% | 1,404,608 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $31.8M | 5.81% | 750,000 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $25.8M | 4.70% | 1,090,441 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $23.1M | 4.23% | 100,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $21.2M | 3.87% | 460,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $20.6M | 3.76% | 17,000,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $19.8M | 3.62% | 1,900,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $18.9M | 3.45% | 340,000 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $16.9M | 3.09% | 3,779,694 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $15.9M | 2.91% | 447,095 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $15.9M | 2.90% | 400,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $15.0M | 2.74% | 537,093 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $14.6M | 2.67% | 1,400,000 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $14.5M | 2.65% | 345,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.4M | 2.44% | 160,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $12.9M | 2.35% | 175,000 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $11.3M | 2.06% | 1,466,465 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $11.2M | 2.05% | 563,824 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $11.1M | 2.03% | 517,554 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $10.0M | 1.82% | 1,550,408 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $9.9M | 1.81% | 356,384 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $8.0M | 1.47% | 1,885,802 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $7.4M | 1.35% | 320,100 | PUT | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $7.1M | 1.30% | 690,112 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $6.3M | 1.16% | 795,729 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $5.9M | 1.08% | 228,277 | Common | SOLE |
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $5.9M | 1.07% | 100,049 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $5.8M | 1.06% | 225,000 | CALL | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $5.7M | 1.05% | 30,000 | CALL | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $5.6M | 1.03% | 500,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.6M | 1.02% | 300,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $5.4M | 0.99% | 1,150,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $4.8M | 0.88% | 550,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $4.5M | 0.82% | 75,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $4.3M | 0.78% | 70,988 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $4.2M | 0.77% | 300,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $4.1M | 0.74% | 100,000 | CALL | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $4.0M | 0.74% | 60,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $4.0M | 0.73% | 50,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.6M | 0.67% | 100,000 | Common | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $3.6M | 0.66% | 6,000,000 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $3.4M | 0.62% | 6,000,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $3.4M | 0.61% | 94,300 | PUT | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $3.3M | 0.60% | 300,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $3.2M | 0.59% | 80,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $3.1M | 0.57% | 25,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $3.1M | 0.56% | 300,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $3.0M | 0.54% | 300,274 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $2.9M | 0.52% | 7,500 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.8M | 0.50% | 191,535 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $2.7M | 0.50% | 121,000 | CALL | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $2.5M | 0.46% | 109,900 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.5M | 0.46% | 20,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $2.3M | 0.42% | 1,000,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $2.1M | 0.38% | 200,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $1.9M | 0.34% | 7,500 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.8M | 0.33% | 68,081 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $1.7M | 0.31% | 1,013,540 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.6M | 0.29% | 25,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.5M | 0.28% | 125,969 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.5M | 0.27% | 25,000 | CALL | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $1.5M | 0.27% | 50,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.4M | 0.26% | 125,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $1.3M | 0.24% | 10,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $1.3M | 0.24% | 20,000 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $1.3M | 0.23% | 400,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $1.2M | 0.23% | 42,670 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.1M | 0.20% | 50,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $893,065 | 0.16% | 20,866 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $876,171 | 0.16% | 202,349 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $843,750 | 0.15% | 125,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $748,980 | 0.14% | 27,000 | PUT | SOLE |
| 05455M100 | — | AVROBIO INC | $680,000 | 0.12% | 500,000 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $546,636 | 0.10% | 187,204 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $428,810 | 0.08% | 137,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $428,340 | 0.08% | 66,000 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $377,500 | 0.07% | 250,000 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $371,563 | 0.07% | 328,817 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $326,158 | 0.06% | 200,097 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $305,852 | 0.06% | 265,958 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $42,863 | 0.01% | 346,511 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $36,750 | 0.01% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.